Study of FG-4592 in Subjects With Chronic Kidney Disease in China

NCT01599507 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia in Chronic Kidney Disease

Interventions

DRUG: FG-4592
DRUG: Placebo

Sponsor

Kyntra Bio